LAS VEGAS — At the Eyecelerator@ASCRS meeting, Tom Mitro, president and chief operating officer at Aerie, discusses candidates that may help Aerie gain a foothold in other ophthalmic disease states, including a pan-VEGF inhibitor.
Uncategorized
VIDEO: Mitro discusses potential avenues for new drug therapies